Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

SELL
$94.19 - $124.49 $186,119 - $245,992
-1,976 Closed
0 $0
Q4 2021

Jan 19, 2022

SELL
$119.57 - $139.07 $232,444 - $270,352
-1,944 Reduced 49.59%
1,976 $253,000
Q3 2021

Oct 21, 2021

SELL
$109.17 - $142.35 $6,550 - $8,541
-60 Reduced 1.51%
3,920 $522,000
Q1 2021

May 18, 2021

SELL
$101.51 - $125.27 $21,824 - $26,933
-215 Reduced 5.13%
3,980 $419,000
Q4 2020

Mar 05, 2021

BUY
$85.88 - $105.36 $360,266 - $441,985
4,195 New
4,195 $437,000
Q1 2020

May 15, 2020

SELL
$36.95 - $62.95 $3,325 - $5,665
-90 Closed
0 $0
Q4 2019

May 15, 2020

BUY
$47.06 - $56.64 $4,235 - $5,097
90 New
90 $5,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Jackson Square Capital, LLC Portfolio

Follow Jackson Square Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Capital, LLC with notifications on news.